Menu
The grades of 10 pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
Healthcare stocks finished down broadly on Wall Street on Tuesday, with the sector seeing an overall decline of 0.4%. More
In the last nine months, the medical marijuana industry in Canada has experienced a paradigm shift that was years in the making. The Canadian government changed the way it grants and distributes licenses for production of medical Cannabis. More
Healthcare stocks rose broadly on Wall Street so far on Monday, with the sector seeing an overall increase of 0.2%. More
This week, four pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
Healthcare stocks declined broadly on Wall Street today, with the sector seeing an overall decline of 0.6%. More
Healthcare stocks rose 0.3% on Wall Street on Thursday morning. More
